Jiajun Chen
Overview
Explore the profile of Jiajun Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
283
Citations
1609
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wang C, Lu M, Chen C, Chen J, Cai Y, Wang H, et al.
Int Immunopharmacol
. 2024 Dec;
145:113752.
PMID: 39642568
Background: Colorectal cancer (CRC) development is a complex, multi-stage process, transitioning from normal to adenomatous tissue, and then to invasive carcinoma. Despite research, there's a knowledge gap on using high-resolution...
12.
Peng Z, Chen G, Zhang J, Liu J, Chen J, Wang J
Heliyon
. 2024 Dec;
10(22):e40042.
PMID: 39634394
To improve the accuracy and portability of fault location in secondary circuits of smart substations, a fault location method for secondary circuits based on graph neural networks is proposed. First,...
13.
Yang Y, Wu Y, Huang J, Tang H, Gao H, Yu J, et al.
Int J Biol Macromol
. 2024 Dec;
284(Pt 2):138189.
PMID: 39617238
A predicted peanut R. solanacearum T3E RS_T3E_Hyp6 was identified as a definite T3E and renamed as RipBU. It is relative conserved in 31 R. solanacearum strains. Deletion of RipBU in...
14.
Liu J, Zhang S, Wang Z, Xia X, Zhang J, Yu Y, et al.
Nat Commun
. 2024 Nov;
15(1):10367.
PMID: 39609449
Optical properties of cholesteric liquid crystal elastomers (CLCEs) can be tuned by an external field, however, it will spontaneously restore to the original state after the field is removed. Here,...
15.
He Y, Ding J, Liu L, Chen J, Zhong H, Li C, et al.
Ann Hematol
. 2024 Nov;
103(12):5285-5296.
PMID: 39586883
Chronic myelogenous leukemia (CML) is a malignant tumor of the blood system, so far there is no effective cure. Imatinib (IM), as the first-line drug for the clinical targeted treatment...
16.
Wu T, Wang T, Hu Y, Chen J, Su J
Front Chem
. 2024 Nov;
12:1465706.
PMID: 39575396
The application of medium-phase microemulsion in enhancing oil recovery technology represents a significant area of research, particularly for improving production in low-permeability reservoirs. The oil recovery can be increased to...
17.
Wang L, Qin Y, Song J, Xu J, Quan W, Su H, et al.
Sci Rep
. 2024 Nov;
14(1):28548.
PMID: 39558055
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by an insidious onset. Despite the emphasis on motor symptom-based diagnosis, there remains an unmet clinical need for effective diagnostic approaches...
18.
Zhou H, Xiao J, Cheng Q, Wang W, Peng H, Lin X, et al.
Eur J Pharmacol
. 2024 Nov;
985:177127.
PMID: 39528101
The growth differentiation factor 15 (GDF15) may serve as a biomarker of metformin, which mediates the bodyweight lowering effect of metformin. However, whether GDF15 also serves as a molecular target...
19.
Chen X, Yue J, Xu X, Chen J, Huang X, Huang Y, et al.
Nanotechnology
. 2024 Nov;
36(6).
PMID: 39514902
Selenium-based nanoparticles exhibit antiviral activity by directly modulating immune function. Despite recent promising developments in utilizing selenium nanoparticles (Se NPs) against viral infections, the impact of surface ligand charge on...
20.
Lin B, Melnikov V, Guo S, Cao Z, Ye Z, Ye Z, et al.
Eur J Endocrinol
. 2024 Oct;
191(5):509-522.
PMID: 39460431
Objective: The aim of this study was to investigate the gut microbial signatures and related pathophysiological implications in patients with Cushing's disease (CD). Design And Methods: Twenty-seven patients with CD...